Last quarter (Q3 2025), Palisade Bio's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Palisade Bio's net income was $-2.87M. See Palisade Bio’s key income statements, including revenue, expenses, profit, and income.

Income Statement	Dec 24	Dec 23	Dec 22	Dec 21	Dec 20
Total Revenue	$ 0.00	$ 250.00K	$ 0.00	$ 0.00	$ 13.52K
Gross Profit	$ 0.00	$ 250.00K	$ 0.00	$ 0.00	$ -132.00K
Operating Expenses	$ 14.86M	$ 13.32M	$ 15.72M	$ 41.85M	$ 9.30M
Depreciation and Amortization	$ 3.00K	$ 4.00K	$ 3.00K	$ 2.00K	$ 146.00K
EBITDA	$ -14.42M	$ -12.28M	$ -14.24M	$ -24.22M	$ -9.94M
Operating Income	$ -14.86M	$ -13.07M	$ -15.72M	$ -41.85M	$ -9.30M
Other Income/Expenses	$ 421.00K	$ 770.00K	$ 1.46M	$ 15.24M	$ -1.02M
Pretax Income	$ -14.44M	$ -12.30M	$ -14.26M	$ -26.62M	$ -10.32M
Net Income	$ -14.44M	$ -12.30M	$ -14.26M	$ -26.62M	$ -10.32M
Per Share Metrics
Basic EPS	$ -10.19	$ -27.01	$ -16.53	$ -2.14K	$ -186.00
Diluted EPS	$ -10.19	$ -27.01	$ -16.53	$ -2.55K	$ -186.00
Weighted Average Shares Outstanding	1.42M	456.01K	880.10K	12.41K	832.30K
Weighted Average Shares Outstanding (Diluted)	1.42M	456.01K	880.30K	12.46K	237.39K

Currency in USD

Palisade Bio Earnings and Revenue History

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing